Clinical Trials on Pneumonia, Pneumococcal

Total 9903 results

Pfizer

Completed

Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults

Pneumococcal Infections

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY)

Pneumococcal Infections

United States, Australia, Canada, Chile, New Zealand, Poland, Russian Federation
Pfizer

Completed

A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age

Pneumococcal Infections

United States
Pfizer

Completed

A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.

Pneumococcal Infections

Japan
Telethon Kids Institute
Papua New Guinea Institute of Medical Research

Completed

PCV13 in Non-pregnant Papua New Guinean Women

Pneumococcal Infections

Papua New Guinea
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)

Pneumococcal Infections

United States, Canada, Denmark, Finland, Israel, Spain
Pfizer

Completed

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age

Pneumococcal Infections

United States
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001)

Pneumococcal Infections
Sinovac Biotech Co., Ltd

Completed

Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly

Pneumococcal Infections

China
SK Chemicals Co., Ltd.

Completed

Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine

Pneumococcal Infections
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children

Pneumococcal Infections

Poland
National Taiwan University Hospital

Recruiting

Treatment of Macrolide-resistant Mycoplasma Pneumoniae

Pneumonia, Mycoplasma

Taiwan
Peking University Third Hospital

Completed

The Relationship Between Hormone Sensitivity and Imaging of Idiopathic Interstitial Pneumonia by Artificial Intelligence (IIP)

Idiopathic Interstitial Pneumonia

China
Meridian Bioscience, Inc.

Completed

Detection of Mycoplasma Pneumoniae

Mycoplasma Pneumoniae

United States
Centers for Disease Control and Prevention

Completed

Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting

Mycoplasma Pneumoniae
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-028)

Pneumococcal Infections

Japan
Sinovac Biotech Co., Ltd

Completed

Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine

Pneumococcal Infections

China
Sinovac Biotech Co., Ltd

Completed

Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine

Pneumococcal Infections

China
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK)

Pneumococcal Infections

United States, Australia, Canada, Finland, Germany, Israel, Malaysia, Peru, Taiwan, Thailand
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033)

Pneumococcal Infections

Japan
Sinovac Biotech Co., Ltd

Completed

A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine

Pneumococcal Infections

China
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE) (PNEU-AGE)

Pneumococcal Infections

Taiwan, United States, Canada, Japan, Spain
Arto Palmu
GlaxoSmithKline

Completed

Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage (FinIPcarr)

Pneumococcal Infections

Finland
SK Chemicals Co., Ltd.

Completed

Immunogenicity and Safety Study of NBP606 in Healthy Toddlers

Pneumococcal Infections

Korea, Republic of
Pfizer

Completed

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age

Pneumococcal Infections

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)

Pneumococcal Infections
Pfizer

Completed

A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years

Pneumococcal Infections

United States
Agence de Médecine Préventive, France

Completed

Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso (PCV13-Bobo)

Pneumococcal Infections

Burkina Faso
Pfizer

Completed

13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico

Pneumococcal Infections

Mexico
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Investigating Administration of Prevenar for Post-Marketing Surveillance

Pneumococcal Infections

Korea, Republic of
Centers for Disease Control and Prevention
Southcentral Foundation; Alaska Native Tribal Health Consortium

Completed

Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders

Pneumococcal Infections

United States
Bayer

Terminated

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP) (RISE-IIP)

Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary

Belgium, Israel, Spain, United States, Switzerland, New Zealand, Greece, Portugal, Japan, Argentina, Canada, Denmark, France, Germany, Russian Federation, Turkey, Colombia, Saudi Arabia, Australia, Italy, United Kingdom
Merck Sharp & Dohme LLC

Completed

A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)

Healthy | Pneumococcal Infections
Central Hospital, Nancy, France

Unknown

Interstitial Pneumonia With Autoimmune Features: Evaluation of Connective Tissue Disease Incidence During Follow-up (EVOLIPAF)

Idiopathic Interstitial Pneumonia

France
Centre Hospitalier Universitaire de Nīmes

Completed

Study of the Impact of an Intervention Performed by a Clinical Pharmacist on Patients at Risk of Pneumococcal Infection at the End of Hospitalization (IP-VAC)

Vaccination

France
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue Fluid (COPandNGS)

Idiopathic Interstitial Pneumonias | Cryptogenic Organizing Pneumonia

China
Duke University
National Heart, Lung, and Blood Institute (NHLBI); Vanderbilt University; National...

Terminated

Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias

Idiopathic Interstitial Pneumonias

United States
Assistance Publique - Hôpitaux de Paris

Completed

Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis

ANCA-associated Vasculitis | Pneumococcal Infection

France
Assistance Publique - Hôpitaux de Paris

Unknown

Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis

ANCA-associated Vasculitis | Pneumococcal Infection

France
Seoul National University Hospital

Unknown

Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis

Pulmonary Tuberculosis | Mycoplasma Pneumonia

Korea, Republic of
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa

Infant | Vaccines, Pneumococcal | Drug Therapy, Combination | Fever, Chemically Induced
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Pneumococcal Vaccine in Healthy Infants

Pneumococcal Infections | Healthy Subjects

United States
Bert Vaes

Recruiting

The Effect of AUDIT and Feedback on Pneumococcal Vaccination Coverage

Pneumococcal Infections

Belgium
GPN Vaccines

Recruiting

Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.

Pneumococcal Infections

Australia
London School of Hygiene and Tropical Medicine
Save the Children; Murdoch Children's Research Institute; Ministry of Health...

Not yet recruiting

Evaluating the Effectiveness of a Pneumococcal Immunisation Campaign in a Camp for Internally Displaced People (EEPICC)

Pneumococcal Infections

Somalia
Jena University Hospital

Completed

Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels

Pneumococcal Infections

Germany
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025) (PNEU-PED-EU-1)

Pneumococcal Infections

Australia, Belgium, Czechia, Estonia, Germany, Greece, Poland, Russian Federation, Spain
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)

Pneumococcal Infections

United States, Australia, Belgium, Brazil, Canada, Colombia, France, Germany, Mexico, Sweden
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) (PNEU-PED-EU-2)

Pneumococcal Infections

Denmark, Finland, Italy, Norway, Sweden
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)

Pneumococcal Infections

United States, Puerto Rico, Thailand, Turkey

3

Subscribe